Cannabis legislation in Germany is evolving. For pharmaceutical companies, Regulatory Affairs, Market Access, and Compliance teams, this means: those who act now secure not only legal certainty but also strategic advantages in a dynamic market.
Our three-part webinar “Comprehensive Overview of Cannabis Legislation in Germany” provides a well-structured and practice-oriented analysis of the current legal framework. You will learn how recent changes impact the medical use of cannabis, prescription processes, and dispensing regulations – and which regulatory requirements you need to know to remain compliant.
Why attend?
- Ensure legal certainty: Understand the key elements of the Cannabis Act and their practical implications.
- Implement efficiently: Receive concrete recommendations for applying regulatory requirements.
- Leverage expert knowledge: Benefit from up-to-date interpretations and strategic insights from experienced speakers. The speakers, Dr. Marcus Geschwandtner and Dr. Angela Graf, are co-editors and authors of the upcoming Beck Commentary Geschwandtner/Graf/Sobota – Cannabis Law (KCanG, MedCanG), to be published in early 2026. They approach current topics with scientific rigor and a strong focus on practical application.
Cannabis legislation is more than a legal issue – it influences market strategies, supply chains, and positioning in the medical cannabis sector. Those who understand the connections can identify opportunities early and minimize risks.
This webinar is designed for professionals and executives in Regulatory Affairs, Market Access, Compliance, and Legal who need to orient themselves quickly and reliably. Take this opportunity to deepen your knowledge and prepare for upcoming challenges.
Learn more and secure your spot: